Calif. stem cell agency aims to bring therapies to trials

06/5/2009 | Bloomberg

The California Institute of Regenerative Medicine plans to provide about $20 million each to 10 or 12 research groups that hope to advance their stem cell treatments to human clinical trials within four years, said Alan Trounson, the agency's president. The agency also hopes to attract pharmaceutical firms that would invest in stem cell research, Trounson said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC